2020
DOI: 10.1016/j.ejphar.2020.173182
|View full text |Cite
|
Sign up to set email alerts
|

Calcium signaling mediated by aminergic GPCRs is impaired by the PI3K inhibitor LY294002 and its analog LY303511 in a PI3K-independent manner

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 35 publications
3
9
0
Order By: Relevance
“…A large proportion of bone trabeculars lost their normal architecture and looked like separate bone areas separated by extended spaces. This is consistent with the results of several researchers (Almarestani et al, 2011) and, according to Noguchi et al (2008), can be caused by activation of inflammation mediators, by means of which stimulation of osteoclastic formation takes place, which eventually leads to periarticular bone resorption (Kotova et al, 2020).…”
Section: Micro-ct Analysissupporting
confidence: 93%
“…A large proportion of bone trabeculars lost their normal architecture and looked like separate bone areas separated by extended spaces. This is consistent with the results of several researchers (Almarestani et al, 2011) and, according to Noguchi et al (2008), can be caused by activation of inflammation mediators, by means of which stimulation of osteoclastic formation takes place, which eventually leads to periarticular bone resorption (Kotova et al, 2020).…”
Section: Micro-ct Analysissupporting
confidence: 93%
“…A large proportion of bone trabeculars lost their normal architecture and looked like separate bone areas separated by extended spaces. This is consistent with the results of several researchers [47] and, according to Noguchi et al [51] can be caused by activation of inflammation mediators, by means of which stimulation of osteoclastic formation takes place, which eventually leads to periarticular bone resorption [52].…”
Section: Micro-ct Analysissupporting
confidence: 93%
“…LY294002 is a specific inhibitor of the PI3K/Akt pathway. It inhibits the activation of PI3K and the phosphorylation of Akt by inhibiting the combination of ATP and PI3K-P85, thereby affecting the transduction of the P13K/Akt pathway [23,24]. LY294002 has similar PI3K/Akt inhibitory efficacy in all cells, but different cell models and different intervention methods have significant differences in tolerability [25,26].…”
Section: Discussionmentioning
confidence: 99%